On July 15, 2016 the European Securities and Markets Authority (ESMA) published version 25 of its questions and answers on prospectuses. These were previously updated in April 2016.
The new questions relate to the dissemination of amended advertisements and the inclusion of Alternative Performance Measures (APMs) in information disclosed about the offer to the public or the admission to trading on a regulated market:
How the requirement to disseminate an amended advertisement at a minimum through the same means as the original advertisement should be applied when the advertisement in question is a roadshow.
ESMA states that the general requirement to amend the roadshow advertisement still applies and therefore, the issuer, offeror or person asking for admission to trading on a regulated market should disseminate an amended version of the information provided in the roadshow through the means which it considers most suitable to reach the participants of the roadshow. Depending on the type of roadshow conducted and the nature of the participants, this might, for example, be by way of a press release, publication on the website of the issuer, offeror or person asking for admission to trading or by direct correspondence with the roadshow participants.
How the issuer, offeror or person asking for admission to trading should proceed in case a participant at a live presentation (e.g. a roadshow/interview) requests information about an APM which is not included in the prospectus, given that Article 12 of Commission Delegated Regulation (EU) 2016/301 states out that only APMs included in the prospectus can be included in information disclosed about the offer to the public or the admission to trading on a regulated market.
ESMA states that, before the prospectus is approved and published, the issuer, offeror or person asking for admission to trading is free to provide information on the APM in question. However, in order to ensure that no APM is included in information disclosed about the offer/admission to trading without being included in the prospectus, the issuer, offeror or person asking for admission to trading should afterwards include the APM in the draft prospectus before this is approved and published, it being understood that the ESMA Guidelines on Alternative Performance Measures should be taken into account.
After the prospectus is approved and published, the issuer, offeror or person asking for admission to trading can proceed in two ways. It can decide to provide information on the APM and afterwards publish a supplement containing this APM, thereby ensuring consistency between the prospectus and the information disclosed about the offer/admission to trading. In such case, the ESMA Guidelines on Alternative Performance Measures should be taken into account. Alternatively, if the issuer, offeror or person asking for admission to trading does not wish to publish a supplement, it should decline to provide information on the APM as there will otherwise be a breach of the requirement set out in Article 12.
(ESMA, Questions and Answers: Prospectuses 25th updated version – July 2016, 15.07.16)